Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.
A deadly disease and modern pharmacological attempts to treat it.
Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.